ADIPOQ and hypertensive disorder: Although the plasma adiponectin level is low in hypertension patients, we hypothesized that the ability of rs1501299 polymorphism to reduce adiponectin level is weaker than the other polymorphisms, thereby allowing for a relatively higher level of serum adiponectin, which suggests to a protective role for this polymorphism hypertension.